US 12,239,825 B1
Drug delivery assembly including an actuator
David R. Schiff, Highland Park, NJ (US); and Sharon D. West, Elkins Park, PA (US)
Assigned to Fresenius Kabi Deutschland GmbH, Bad Homburg (DE)
Filed by Fresenius Kabi Deutschland GmbH, Bad Homburg (DE)
Filed on Jul. 27, 2022, as Appl. No. 17/875,031.
Application 17/875,031 is a continuation of application No. 17/180,578, filed on Feb. 19, 2021, granted, now 11,426,523.
Int. Cl. A61M 5/315 (2006.01); A61M 5/142 (2006.01)
CPC A61M 5/31501 (2013.01) [A61M 5/14248 (2013.01); A61M 5/31585 (2013.01); A61M 2005/14252 (2013.01); A61M 2005/14268 (2013.01); A61M 2202/0007 (2013.01); A61M 2209/088 (2013.01)] 25 Claims
OG exemplary drawing
 
1. A drug delivery assembly comprising:
a housing including an upper surface, a lower surface, and a sidewall extending from the upper surface to the lower surface;
an adhesive pad associated with the lower surface of the housing;
a controller positioned within the housing and configured to execute a drug delivery routine;
an actuator associated with the sidewall of the housing and at least partially positioned within the housing;
a drug reservoir positioned within the housing and having a central axis; and
a needle movably associated with the drug reservoir, wherein
the actuator is configured to be moved in a direction toward the needle from a first position to a second position,
movement of the actuator from the first position to the second position with respect to the drug reservoir is only at an angle to the central axis of the drug reservoir and causes movement of at least a portion of the needle in a direction toward the adhesive pad, and
the direction of movement of said at least a portion of the needle is generally perpendicular to the direction of movement of the actuator.